AXL and cancer: AXL expression is up-regulated in numerous human malignancies, such as leukaemia, breast cancer, prostate cancer [3], kidney cancer [4], melanoma [5], glioblastoma [6] and non-small lung cancer [7], and it is associated with cancer progression, therapy resistance and poor prognosis [8–11].